Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer

European Respiratory Journal

Volumn 14, Issue 2, 1999, Pages 412-418

  Watkins, D N ^a,b   Lenzo, J C ^a   Segal, A ^a   Garlepp, M J ^a,c   Thompson, P J ^a  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Adenocarcinoma; Cyclo oxygenase; Immunohistochemistry; In situ hybridization; Non small cell lung cancer; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 1; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADENOMATOUS POLYP; ARTICLE; COLON POLYP; ENZYME LOCALIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; LUNG; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0032821662     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14b28.x     Document Type: Article

References (36)

1. Mountain CF. New prognostic factors in lung cancer. Chest 1995; 108: 246-254.
2. Holtzman MJ. Arachidonic acid metabolism in airway epithelial cells. Ann Rev Physiol 1992; 54: 303-329.
3. Watkins DN, Garlepp MJ, Thompson PJ. Regulation of the inducible cyclooxygenase pathway in cultured human airway epithelial cells by nitric oxide. Br J Pharmacol 1997; 12: 1482-1488.
4. Watkins DN, Peroni DJ, Lenzo JC, Knight DA, Garlepp MJ, Thompson PJ. Expression and localisation of the inducible isoform of cyclooxygenase (COX-2) in human airways and cultured human airway epithelial cells. Eur Respir J 1999; in press.
5. Sigal E. The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol 1991; 260: L13-L28.
6. DeWitt D, Smith WL. Yes, but do they still get headaches? Cell 1993; 361: 345-348.
7. Herschmann HR. Regulation of prostaglandin synthase 1 and prostaglandin synthase 2. Cancer Metastasis Rev 1994; 241: 241-256.
8. Gustafson-Svard C, Lilija I, Hallbook O, Sjodahl R. Cyclo-oxygenase and colon cancer: clues to the aspirin effect? Ann Med 1997; 29: 247-252.
9. Sano H, Kawahito Y, Wilder RL. Expression of cyclooxygenase 1 and 2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789.
10. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase 1 and 2 protein in human colon cancer. Cancer Res 1995; 55: 2556-2559.
11. Rigas B, Goldman IS, Levine L. Altered eicosanoids levels in human colon cancer. J Lab Clin Med 1993; 122: 518-523.
12. Piazza GA, Rahm AK, Finn TS, et al. Apoptosis primarily accounts for the growth inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res 1997; 57: 2452-2459.
13. Spagnesi M, Tonelli F, Dolara P. Rectal proliferation and polyp recurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 1994; 106: 362-366.
14. Ara G, Teicher BA. cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 3-16.
15. Tsujii M, Kawano S, Tsuji S, Sawaoka S, Hori M, Du Bois RN. cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705-716.
16. Hubbard WC, Alley MC, McLemore TL, Boyd MR. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate and ovarian tumours. Cancer Res 1988; 48: 4770-4775.
17. Hubbard WC, Alley MC, Gray GN, Green KC, McLemore TL, Boyd MR. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumours. Cancer Res 1989; 49: 826-832.
18. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, Thompson PJ. Expression and activity of nitric oxide syntheses in human airway epithelium. Am J Respir Cell Mol Biol 1997; 16: 629-639.
19. Detre S, Saccani Jotti G, Dowsett M. A quickscore method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995; 48: 876-878.
20. Iseki S. Immunocytochemical localisation of cyclooxygenase 1 and cyclooxygenase 2 in the rat stomach. Histochem J 1995; 27: 323-328.
21. Page RM, Cole GE, Timmreck TC. Basic epidemiological methods and biostatistics: a practical guidebook. (First ed.) Boston, Jones and Bartlett, 1995.
22. Hida T, Yatabe Y, Achiwa H, et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998; 58: 3761-3764.
23. 2α in benign and malignant breast tumours. Br J Cancer 1985; 51: 827-836.
24. McLemore TL, Hubbard WC, Litterst CL, et al. Profiles of prostaglandin biosynthesis in normal lung and tumour tissue from lung cancer patients. Cancer Res 1988; 48: 3140-3147.
25. Lupulescu A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 83-94.
26. 2 producing nonmetastatic lewis lung carcinoma variants. Cancer Res 1990; 50: 2973-2978.
27. Chiabrando C, Broggini M, Castagnoli MN. Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth. Cancer Res 1985; 45: 3605-3608.
28. 2 expression in tracheal epithelium. Am J Physiol 1996; 270: L854-862.
29. DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase 2 levels in carcinogen induced rat colonie tumours. Gastroenterology 1996; 110: 1259-1262.
30. Singh J, Hamid R, Reddy SS. Dietary fat and colon cancer: modulation of cyclooxygenase 2 by types and amount of dietary fat during the post-initiation stage of colon carcinogenesis. Cancer Res 1997; 57: 3465-3470.
31. Hanif R, Pittas A, Feng Y, et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin independent pathway. Biochem Pharmacol 1996; 52: 237-245.
32. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase 2. J Clin Invest 1997; 99: 2254-2259.
33. Goppelt-Stuebe M. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 213-222.
34. Subbaramaiah K, Telang N, Ramonetti JT, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996; 56: 4424-4429.
35. 2 by oncogenic ras in human non small cell lung cancer. J Biol Chem 1997; 272: 14501-14504.
36. Carbone DP, Minna JD. The molecular genetics of lung cancer. Adv Internal Med 1997; 37: 153-171.